Erythromycin [clinicaltrials_resource:6255f11142235e41d912f2830a49507d]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00331643 [clinicaltrials_resource:04e94b8a43da0e6fb95715b99650bb9c]eligibility for clinicaltrials:NCT00107536 [clinicaltrials_resource:273f28a85c6566d76ff76854cd53b9fb]eligibility for clinicaltrials:NCT00070109 [clinicaltrials_resource:2be59c7deb57fbbf3509352ef6f891c2]eligibility for clinicaltrials:NCT00134069 [clinicaltrials_resource:31c44eb02996a6c0ff1a0b62791f3b16]eligibility for clinicaltrials:NCT00118157 [clinicaltrials_resource:38c27da684633d4e18d079b4d14c3854]eligibility for clinicaltrials:NCT00397787 [clinicaltrials_resource:44f7445b33573724f39d2c3350c2edd2]eligibility for clinicaltrials:NCT00301756 [clinicaltrials_resource:5be956883f0e12d02fa5f13b3bd89e15]eligibility for clinicaltrials:NCT01159301 [clinicaltrials_resource:655c301682c937d4832cd67c710c7054]eligibility for clinicaltrials:NCT00410904 [clinicaltrials_resource:740cb91f749a254954ae598a778f0c17]eligibility for clinicaltrials:NCT00378911 [clinicaltrials_resource:90e2573b962fa7b00d8bc3d81c673d4b]eligibility for clinicaltrials:NCT00096499 [clinicaltrials_resource:a07408bbc65c5b2266e419ce0526be68]eligibility for clinicaltrials:NCT00906360 [clinicaltrials_resource:ab102d1f180ab3114d9eef4e4cd8cffd]eligibility for clinicaltrials:NCT00387920 [clinicaltrials_resource:ae648621e7eda92397728786d3a31e65]eligibility for clinicaltrials:NCT00398112 [clinicaltrials_resource:baa879f991df91a619bf63a4eb76ddf8]eligibility for clinicaltrials:NCT00321594 [clinicaltrials_resource:bb6f8a91caf17688756b2aea0fc0a8a3]eligibility for clinicaltrials:NCT00070525 [clinicaltrials_resource:bbc57e24ec459e18f6e64dc2c331a766]eligibility for clinicaltrials:NCT00119236 [clinicaltrials_resource:d8177edb3af609f1c135ac1b3cd473fc]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Clinical Trial of Eye Prophylaxis in the Newborn [clinicaltrials:NCT00000120]An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. [clinicaltrials:NCT00002194]Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission [clinicaltrials:NCT00021671]UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer [clinicaltrials:NCT00146042]Effects of Long Term Macrolide Antibiotic Therapy in Patients With COPD [clinicaltrials:NCT00147667]Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer [clinicaltrials:NCT00148070]clinicaltrials:NCT00304187The Effect of Concomitant Administration of Erythromycin and Diltiazem on CYP3A Activity in Healthy Volunteers [clinicaltrials:NCT00318201]Use of Erythromycin in Mustard-Induced Bronchiolitis [clinicaltrials:NCT00367419]Chronic Bronchiolitis or Resistant Asthma? [clinicaltrials:NCT00368342]The Effect of Erythromycin on Occurrence of Leaks From Cervical Esophageal-Gastric Anastomosis After Trans-Hiatal Esophagectomy [clinicaltrials:NCT00373919]clinicaltrials:NCT00467831Antibiotics and the Prolongation of Pregnancy in Preterm Labor With an Advanced Cervical Exam [clinicaltrials:NCT00589329]An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia [clinicaltrials:NCT00648726]clinicaltrials:NCT00718315To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil [clinicaltrials:NCT00770042]The Effect of Intravenous Erythromycin on Gastric Emptying in Non-fasted Patients Before Emergency Total Anesthesia [clinicaltrials:NCT00827216]Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube [clinicaltrials:NCT00999232]Intravenous Erythromycin Before Endoscopy in Patients With Variceal Bleeding: A Randomized, Double-Blind Trial [clinicaltrials:NCT01060267]Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy [clinicaltrials:NCT01097811]Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients [clinicaltrials:NCT01117376]Neuroprotection With Erythromycin in Cardiac Surgery [clinicaltrials:NCT01274754]clinicaltrials:NCT01309438TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r) [clinicaltrials:NCT01323257]clinicaltrials:NCT01323582Selections of Subjects With Important Changes in Their Cardiac Repolarization Parameters for the Procurement of Skin and Blood Samples [clinicaltrials:NCT01338441]Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin [clinicaltrials:NCT01340235]An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet [clinicaltrials:NCT01342198]clinicaltrials:NCT01379183Antibiotics Study in Preterm Premature Rupture of the Membranes [clinicaltrials:NCT01401179]PPROM Erythromycin Versus Azithromycin [clinicaltrials:NCT01431248]clinicaltrials:NCT01478256Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes [clinicaltrials:NCT01556334]Use of Prokinetics in Early Enteral Feeding in Preterm Infants [clinicaltrials:NCT01569633]A Study To Investigate The Effect Of Erythromycin On The Pharmacokinetics Of PH-797804 [clinicaltrials:NCT01589614]clinicaltrials:NCT01592708Incidence of Infection After Total Knee Arthroplasty Using an Erythromycin and Colistin Loaded Cement or a Standard Cement [clinicaltrials:NCT01631968]Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stasis [clinicaltrials:NCT01659619]Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer [clinicaltrials:NCT01668498]clinicaltrials:NCT01716572
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Erythromycin [clinicaltrials_resource:6255f11142235e41d912f2830a49507d]
Bio2RDF identifier
6255f11142235e41d912f2830a49507d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6255f11142235e41d912f2830a49507d
identifier
clinicaltrials_resource:6255f11142235e41d912f2830a49507d
title
Erythromycin
@en
type
label
Erythromycin [clinicaltrials_resource:6255f11142235e41d912f2830a49507d]
@en